SCHEMBL3725218

SCHEMBL3725218

CCOC(=O)C(CCOCc1ccccc1)(C(=O)OCC)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 2/20 0.47
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 4/20 0.44
RECQL P46063 1/20 0.44
PIN1 Q13526 1/20 0.42
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
SCN1A P35498 3/20 0.40
SCN2A Q99250 3/20 0.40
SCN3A Q9NY46 3/20 0.40
LMNA P02545 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CHRM2 P08172 2/20 0.39
CHRM4 P08173 2/20 0.39
CHRM1 P11229 2/20 0.39
CHRM3 P20309 2/20 0.39
CYP3A4 P08684 2/20 0.39
TSHR P16473 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14783256 0.90 L3MBTL1 (0.45) MMP8MEN1GAAKMT2AALDH1A1
SCHEMBL11425963 0.87 CHRM3 (0.48) MEN1KMT2AALDH1A1MAPTL3MBTL1
SCHEMBL9213213 0.86 ALDH1A1 (0.46) MMP8MEN1GAAKMT2AALDH1A1
SCHEMBL9115091 0.84 MMP8 (0.50) MMP8MEN1GAAKMT2AALDH1A1
SCHEMBL9116769 0.84 MMP8 (0.57) MMP8MEN1GAAKMT2AALDH1A1
SCHEMBL13351394 0.83 SCN1A (0.43) MMP8MEN1KMT2AALDH1A1RECQL
SCHEMBL28675737 0.82 MMP8 (0.48) MMP8MEN1GAAKMT2AALDH1A1
SCHEMBL8762924 0.81 PIN1 (0.45) MMP8MEN1KMT2AALDH1A1RECQL
SCHEMBL9115819 0.81 MMP8 (0.47) MMP8MEN1GAAKMT2AALDH1A1
SCHEMBL22087971 0.81 MMP8 (0.53) MMP8MEN1GAAKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. 2010-06-24 US disclosed
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. 2010-06-24 US disclosed
US-7625948-B2 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2009-12-01 US disclosed
US-7625948-B2 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2009-12-01 US disclosed
US-20050075367-A1 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-04-07 US disclosed
EP-1479666-A1 ESTER COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075367-A1 Ester compound and medicinal use thereof LIPC, CES1, MTTP MMP8 2989/4885MEN1 2645/4885GAA 2055/4885
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF LIPC, CES1, MTTP MMP8 2623/4885MEN1 2283/4885GAA 1962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.